Skip to main content

Table 1 Patient information for the CSF analysis

From: Upregulation of MIF as a defense mechanism and a biomarker of Alzheimer’s disease

Subjects

Sample size (female/male)

Age (mean ± SD)

Control

30 (14/16)

61.2 ± 9.6

AD

28 (14/14)

69.4 ± 6.8

MCI

10 (4/6)

68.9 ± 9.6

VD

17 (8/9)

66.3 ± 10.2